CANCERTAIN LIMITED

Active Cheadle

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CANCERTAIN LIMITED

Research and experimental development on biotechnology

Founded 25 Jan 2017 Active Cheadle, England 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

CLYZ LABS LIMITED 25 Jan 2017 — 31 Aug 2021
Accounts Submitted 28 Oct 2025 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 31 May 2025 Next due 12 Apr 2026 23 days overdue
Net assets £246K £181K 2023 year on year
Total assets £284K £158K 2023 year on year
Total Liabilities £37K £23K 2023 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

222 Kingsway Gatley Cheadle SK8 4PB England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CANCERTAIN LIMITED (10583623), an active life sciences and medical technology company based in Cheadle, England. Incorporated 25 Jan 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£33.64k

Decreased by £148.04k (-81%)

Net Assets

£246.41k

Decreased by £180.83k (-42%)

Total Liabilities

£37.10k

Increased by £22.84k (+160%)

Turnover

N/A

Employees

7

Debt Ratio

13%

Increased by 10 (+333%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 1

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 3Mar 2018Seed
Investor 1Aug 2018Seed
Investor 2Aug 2018Seed

Share Capital

Share Capital

Share allotments and capital structure

22 Allotments 1,416,893 Shares £746k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 Nov 2025492,174£4.922£4.922
7 Nov 2025149,376£75k£75k
3 Nov 2022150,000£150k£1
3 Nov 202284,023£84k£1
22 Jul 201958,500£63k£1.08

Officers

Officers

3 active
Status
David Mark WhitcombeDirectorBritishEngland631 Feb 2021Active
Himanshu Laxmidas KatariaDirectorBritishEngland4625 Jan 2017Active
Zalakben Himanshu KatariaDirectorIndianUnited Kingdom4025 Jan 2017Active

Shareholders

Shareholders (39)

The Gm & Cheshire Life Sciences Fund L.p.
26.9%
Himanshu Laxmidas Kataria
24.2%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Himanshu Laxmidas Kataria

British

Active
Notified 25 Jan 2017
Residence England
DOB June 1979
Nature of Control
  • Significant Influence Or Control

Zalakben Himanshu Kataria

Indian

Active
Notified 25 Jan 2017
Residence United Kingdom
DOB February 1986
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026CapitalAllotment of shares (GBP 75,784.41335) on 20 Apr 2026
12 Nov 2025CapitalAllotment of shares (GBP 46.91335) on 7 Nov 2025
11 Nov 2025ResolutionResolutions
11 Nov 2025IncorporationMemorandum Articles
28 Oct 2025AccountsAnnual accounts made up to 31 Jan 2025
21 Apr 2026 Capital

Allotment of shares (GBP 75,784.41335) on 20 Apr 2026

12 Nov 2025 Capital

Allotment of shares (GBP 46.91335) on 7 Nov 2025

11 Nov 2025 Resolution

Resolutions

11 Nov 2025 Incorporation

Memorandum Articles

28 Oct 2025 Accounts

Annual accounts made up to 31 Jan 2025

Recent Activity

Latest Activity

Allotment of shares (GBP 75,784.41335) on 20 Apr 2026

1 weeks ago on 21 Apr 2026

Allotment of shares (GBP 46.91335) on 7 Nov 2025

5 months ago on 12 Nov 2025

Resolutions

5 months ago on 11 Nov 2025

Memorandum Articles

5 months ago on 11 Nov 2025

Annual accounts made up to 31 Jan 2025

6 months ago on 28 Oct 2025